| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1014059236 |
| P356 | DOI | 10.1186/1465-9921-8-74 |
| P932 | PMC publication ID | 2238754 |
| P698 | PubMed publication ID | 17967178 |
| P5875 | ResearchGate publication ID | 5879346 |
| P2093 | author name string | Zohar Bromberg | |
| Yoram G Weiss | |||
| Ariella Oppenheim | |||
| Mahmoud Abd El-Latif | |||
| Evelyn Zeira | |||
| Luminita Eid | |||
| P2860 | cites work | Enhanced heat shock protein 70 expression alters proteasomal degradation of IkappaB kinase in experimental acute respiratory distress syndrome | Q45871032 |
| Factors influencing the production of recombinant SV40 vectors | Q45878373 | ||
| Liver-targeted gene therapy by SV40-based vectors using the hydrodynamic injection method | Q45882551 | ||
| Intratumoral injection of dendritic cells transduced by an SV40-based vector expressing interleukin-15 induces curative immunity mediated by CD8+ T lymphocytes and NK cells | Q45883837 | ||
| Use of SV40 to immunize against hepatitis B surface antigen: implications for the use of SV40 for gene transduction and its use as an immunizing agent | Q45889779 | ||
| Adenoviral vector transfection into the pulmonary epithelium after cecal ligation and puncture in rats. | Q51344838 | ||
| Cecal ligation and double puncture impairs heat shock protein 70 (HSP-70) expression in the lungs of rats. | Q51422633 | ||
| Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS | Q73251052 | ||
| High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-kappaB activation | Q73766164 | ||
| Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? | Q77168940 | ||
| Gene therapy for pulmonary diseases | Q80237315 | ||
| The caveolae-mediated sv40 entry pathway bypasses the golgi complex en route to the endoplasmic reticulum | Q24795950 | ||
| Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network | Q27861021 | ||
| SV40-transformed simian cells support the replication of early SV40 mutants | Q28263905 | ||
| Incidence and outcomes of acute lung injury | Q29615139 | ||
| The acute respiratory distress syndrome | Q29615140 | ||
| The pathophysiology and treatment of sepsis | Q29619103 | ||
| Virus entry: open sesame | Q29619349 | ||
| SV40 and human cancer: a review of recent data | Q31080786 | ||
| Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations | Q33893291 | ||
| Gene therapy for pulmonary diseases | Q34137031 | ||
| Gangliosides are receptors for murine polyoma virus and SV40 | Q34225546 | ||
| Caveolae in the uptake and targeting of infectious agents and secreted toxins | Q34365153 | ||
| Is there a role for SV40 in human cancer? | Q34565021 | ||
| SV40 Pseudovirion gene delivery of a toxin to treat human adenocarcinomas in mice. | Q34695978 | ||
| Simian virus-40 as a gene therapy vector. | Q35787827 | ||
| SV40 pseudovirions as highly efficient vectors for gene transfer and their potential application in cancer therapy. | Q35950104 | ||
| What they are, how they work and why they do what they do? The story of SV40-derived gene therapy vectors and what they have to offer | Q36107577 | ||
| The alveolar-epithelial barrier: a target for potential therapy | Q36645134 | ||
| Class I major histocompatibility proteins as cell surface receptors for simian virus 40. | Q36831325 | ||
| Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5. | Q38953236 | ||
| Adenoviral transfer of HSP-70 into pulmonary epithelium ameliorates experimental acute respiratory distress syndrome | Q39738431 | ||
| Replication-deficient rSV40 mediate pancreatic gene transfer and long-term inhibition of tumor growth | Q40228737 | ||
| Participation of pulmonary alveolar epithelial cells in lung inflammation | Q40460967 | ||
| Hepatitis B virus enhances transduction of human hepatocytes by SV40-based vectors | Q40560002 | ||
| High cloning capacity of in vitro packaged SV40 vectors with no SV40 virus sequences. | Q40667017 | ||
| A new packaging cell line for SV40 vectors that eliminates the generation of T-antigen-positive, replication-competent recombinants | Q40680584 | ||
| Durability of transgene expression and vector integration: recombinant SV40-derived gene therapy vectors | Q40713340 | ||
| In vitro-packaged SV40 pseudovirions as highly efficient vectors for gene transfer. | Q40754575 | ||
| Type II alveolar cell. Defender of the alveolus | Q40778453 | ||
| A replication-deficient rSV40 mediates liver-directed gene transfer and a long-term amelioration of jaundice in gunn rats | Q40845754 | ||
| A sensitive and versatile bioluminescence bioassay for HIV type 1 based on adenoviral vectors | Q40950767 | ||
| In vitro assembly of SV40 virions and pseudovirions: vector development for gene therapy | Q41113914 | ||
| The vector void in gene therapy | Q44308364 | ||
| Imaging transgene expression in live animals | Q45198958 | ||
| Liver transduction with a simian virus 40 vector encoding insulin-like growth factor I reduces hepatic damage and the development of liver cirrhosis | Q45411464 | ||
| P921 | main subject | vector-borne disease | Q2083837 |
| gene therapy | Q213901 | ||
| SV40 | Q734305 | ||
| P304 | page(s) | 74 | |
| P577 | publication date | 2007-10-29 | |
| P1433 | published in | Respiratory Research | Q7315904 |
| P1476 | title | Simian virus 40 vectors for pulmonary gene therapy | |
| P478 | volume | 8 |
| Q90624330 | Assembly and Stability of Simian Virus 40 Polymorphs |
| Q35745720 | Electroporation-mediated in vivo gene delivery of the Na+/K+-ATPase pump reduced lung injury in a mouse model of lung contusion |
| Q55303647 | How Simian Virus 40 Hijacks the Intracellular Protein Trafficking Pathway to Its Own Benefit … and Ours. |
Search more.